Holen Sie sich die Stockscreener-App
6.66
2.59%
-0.21
Schlusskurs vom Vortag:
$6.87
Offen:
$6.8
24-Stunden-Volumen:
291.33K
Relative Volume:
0.17
Marktkapitalisierung:
$358.49M
Einnahmen:
$217.25M
Nettoeinkommen (Verlust:
$-50.92M
KGV:
-6.66
EPS:
-1
Netto-Cashflow:
$-100.85M
1W Leistung:
+0.18%
1M Leistung:
+6.90%
6M Leistung:
-52.97%
1J Leistung:
-70.01%
1-Tages-Spanne:
$6.61
$6.815
1-Wochen-Bereich:
$6.61
$7.33
52-Wochen-Spanne:
$4.32
$23.66
Prothena Corporation Plc Stock (PRTA) Company Profile
Firmenname
Prothena Corporation Plc
Sektor
Branche
Telefon
011-353-1-236-2500
Adresse
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Vergleichen Sie PRTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
6.66 | 370.33M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.53 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
548.24 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
394.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
674.30 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.67 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-05-27 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-05-27 | Herabstufung | Jefferies | Buy → Hold |
| 2025-05-27 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-12-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-01-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-04-24 | Eingeleitet | SVB Securities | Outperform |
| 2023-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2022-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-06-18 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-06-08 | Bestätigt | Oppenheimer | Outperform |
| 2021-05-26 | Eingeleitet | Citigroup | Buy |
| 2021-02-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | Hochstufung | Jefferies | Hold → Buy |
| 2021-02-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-12-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2019-11-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-05-21 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2018-04-23 | Herabstufung | Jefferies | Buy → Hold |
| 2018-04-05 | Bestätigt | Barclays | Overweight |
| 2017-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2017-09-29 | Bestätigt | BTIG Research | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Jefferies | Buy |
| 2017-04-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-04-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-03-02 | Eingeleitet | Instinet | Buy |
| 2016-12-21 | Eingeleitet | SunTrust | Buy |
| 2016-11-03 | Eingeleitet | Deutsche Bank | Buy |
| 2016-08-04 | Bestätigt | Barclays | Overweight |
| 2016-05-13 | Eingeleitet | Barclays | Overweight |
| 2016-02-19 | Bestätigt | Wedbush | Outperform |
| 2016-01-21 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Prothena Corporation Plc Aktie (PRTA) Neueste Nachrichten
Intraday pattern recognizer results for Prothena Corporation plcFree Fast Entry High Potential Stock Alerts - Newser
Volume spikes in Prothena Corporation plc stock – what they meanWeekly Breakout Forecast with Entry Zones - Newser
How many analysts rate Prothena Corporation plc as a “Buy”Pre Market Recommendation With Low Risk - jammulinksnews.com
Can technical indicators confirm Prothena Corporation plc’s reversalCommunity Picked Stocks with Trade Insights - Newser
How Prothena Corporation plc stock performs during market volatilityDay Trading Plan with Entry Risk Management - Newser
Ranking Prothena Corporation plc among high performing stocks via toolsReal-Time Setup Summary with ROI Focus - Newser
Prothena Secures Leadership with New Executive Agreements - TipRanks
Sector ETF performance correlation with Prothena Corporation plcMarket Entry and Exit Point Tips From Traders - metal.it
Is Prothena Corporation plc a Top Dividend Stock to Watch in 2025Market Entry and Exit Point Tips From Traders - metal.it
How to build a dashboard for Prothena Corporation plc stockTrading Volume Anomaly Summary and Insight - Newser
What makes Prothena Corporation plc stock price move sharplyIntelligent Trade Forecast With AI Analytics - Newser
Is There Enough Volume to Lift Prothena Corporation plcWeekly Top Gainers Forecast Watchlist Released - metal.it
Is it the right time to buy Prothena Corporation plc stockExpert Picks Forecasts Backed By Experts - jammulinksnews.com
Prothena Corporation plc Company Revenue and Profit Trends: A Deep DiveFree Fundamental + Technical Hybrid Stock Tips - Newser
Will Prothena Corporation plc see short term momentumFree Sector Rotation Based Trading Opportunities - Newser
Why Prothena Corporation plc stock attracts strong analyst attentionValue Holding Return Summary With Outlook - Newser
Bollinger Band Squeeze Points to Volatility in Prothena Corporation plcGrowth Based Investment Plan Guidance Highlighted - metal.it
Prothena to Report Second Quarter 2025 Financial Results on August 4 - BioSpace
Prothena Corporation plc Company Revenue and Profit Trends: A Deep Dive Free Buy Alerts With Low Risk Confirmation - metal.it
Is Prothena Corporation plc a growth stock or a value stockPre Market Planner For Beginners - jammulinksnews.com
How strong is Prothena Corporation plc company’s balance sheetUnlock powerful trading signals and alerts - jammulinksnews.com
How Prothena Corporation plc stock performs during market volatility Free Breakout Momentum Picks With Protection - Newser
What are Prothena Corporation plc company’s key revenue driversUnlock daily market insights for better decisions - jammulinksnews.com
How does Prothena Corporation plc generate profit in a changing economyMaximize returns with expert trading insights - jammulinksnews.com
What institutional investors are buying Prothena Corporation plc stockFree Predictions - jammulinksnews.com
New Product Launches: Will They Boost Prothena Corporation plc Stock in 2025Big Profit Small Risk Alerts - Newser
What is Prothena Corporation plc company’s growth strategyUnlock high-yield investment opportunities - jammulinksnews.com
What analysts say about Prothena Corporation plc stockFree Market Volatility Navigation Tips - PrintWeekIndia
Prothena Corporation plc Stock Analysis and ForecastDynamic investment opportunities - Autocar Professional
Is Prothena Corporation plc a good long term investmentHigh-yield investments - PrintWeekIndia
What drives Prothena Corporation plc stock priceFree Stock Market Real-Time Monitoring - PrintWeekIndia
Prothena Corporation plc (NASDAQ:PRTA) Receives $31.50 Average Price Target from Analysts - Defense World
Finanzdaten der Prothena Corporation Plc-Aktie (PRTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Prothena Corporation Plc-Aktie (PRTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 10% Owner |
May 06 '25 |
Sale |
7.64 |
1,984,053 |
15,164,712 |
5,304,596 |
| EcoR1 Capital, LLC | 10% Owner |
May 05 '25 |
Sale |
8.11 |
977,693 |
7,930,166 |
7,288,649 |
| SCULLY WILLIAM P | 10% Owner |
Jan 14 '25 |
Buy |
12.79 |
100,000 |
1,279,040 |
735,993 |
| SCULLY WILLIAM P | 10% Owner |
Dec 18 '24 |
Buy |
13.93 |
73,436 |
1,022,670 |
1,297,693 |
| SCULLY WILLIAM P | 10% Owner |
Dec 31 '24 |
Buy |
13.01 |
32,000 |
416,393 |
650,193 |
| SCULLY WILLIAM P | 10% Owner |
Dec 20 '24 |
Buy |
15.91 |
2,000 |
31,813 |
618,693 |
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):